Skip to main content
SpringerLink
Log in

Klasse-I-Antiarrhythmika: Wer soll behandelt werden?

  • Conference paper
Medikamentöse Behandlung des Postinfarktpatienten nach CAST

  • 19 Accesses

Zusammenfassung

Die antiarrhythmische Behandlung von Patienten nach Myokardinfarkt verfolgt unabhängig von der Art der registrierten Arrhythmie drei Ziele: die subjektiven Beschwerden beseitigen, eine hämodynamisch ungünstige Situation beheben oder die Prognose verbessern (Tabelle 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ahlmark G, Saetre H, Korsgren M (1974) Reduction of sudden death after myocardial infarction. Lancet 2: 1563

    Article  PubMed  CAS  Google Scholar 

  2. Australian and Swedish pindolol study group (1983) The effect of pindolol on the two years mortality after complicated myocardial infarction. Eur Heart J 4: 367–375

    Google Scholar 

  3. Baber NS, Evans DW, Howitt G, Thomas M, Wilson C, Lewis JA, Dawe PM, Handler K, Tuson R (1980) Multicenter postinfarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Br Heart J 44: 96–100

    Article  PubMed  CAS  Google Scholar 

  4. Bastian BC, Macfarlane PW, Mclauchlan JH, Ballantyne D, Clark R, Hillis WS, Rae AP, Hutton MB, Hutton I (1980) A prospective randomized trial of tocainide in patients following myocardial infarction. Am Heart J 100: 1017–1022

    Article  PubMed  CAS  Google Scholar 

  5. Beta blocker heart attack trial research group (1982) A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. J Am Med Assoc 247: 1707–1714

    Article  Google Scholar 

  6. Budde T, Borggrefe M, Podczek A, Breithardt G (1987) Möglichkeiten und Grenzen der Katheterablation von tachykarden Herzrhytmusstörungen. Z Kardiol 76: 591–607

    PubMed  CAS  Google Scholar 

  7. Cardiac arrhythmia suppression trial (CAST) investigators (1989) Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl J Med 321: 406–412

    Article  Google Scholar 

  8. Chamberlain DA, Julian DG, Boyle DM, Jewitt DE, Campbell RWF, Shanks RG (1980) Oral mexiletine in high risk patients after myocardial infarction. Lancet 2: 1324–1327

    Article  PubMed  CAS  Google Scholar 

  9. Collaborative group (1971) Phenytoin after recovery from myocardial infarction. Controlled trial in 568 patients. Lancet 2: 1055–1057

    Google Scholar 

  10. Denniss AR, Ross L, Cody DV, Russell PA, Young AA, Richards DA, Uther JB (1988) Randomized controlled trial of prophylactic antiarrhythmic therapy in patients with inducible ventricular tachyarrhythmias after recent myocardial infarction. Eur Heart J 9: 746–57

    PubMed  CAS  Google Scholar 

  11. Editorial (1979) Controlled trials: Planned deception? Lancet I: 534–535

    Google Scholar 

  12. Gomes JA, Winters SL, Steward D, Horowitz S, Milner M, Barreca PA (1987) New noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: Based on signal averaged electrogram, radionuclide ejection fraction and Holter monitoring. J Am Coll Cardiol 10: 349–357

    Google Scholar 

  13. Gottlieb SH, Achuff SC, Mellits ED, Gerstenblith G, Banghman KL, Becker L, Chandra NC, Henley S, Humphries JO, Heck C, Kennedy MM, Weisfeld ML, Reid PR (1987) Prophylactic antiarrhythmic therapy of high-risk survivors of myocardial infarction: Lower mortality at 1 month but not at 1 year. Circulation 75: 792–799

    Article  PubMed  CAS  Google Scholar 

  14. Graboys TB, Lown B, Podrid PJ, Desilva R (1982) Longterm survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol 50: 437–443

    Article  PubMed  CAS  Google Scholar 

  15. Hansteen V, Moinichen E, Lorentsen E, Andersen A, Strom O, Soiland K, Dyrbekk D, Refsum AM, Tromsdal A, Knusen K, Eika C, Bakken J (1982) One year’s treatment with propranolol after myocardial infarction: Preliminary report of norwegian multicenter trial. Br Med J 284: 155–160

    Google Scholar 

  16. Herlitz J, Elmfeld, Holmberg S, Malek I, Nyberg I, Pennert K, Ryden L, Swedberg K, Vedin A, Waagstein, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C, Hjalmarson A (1984) Gøteborg metoprolol trial: Mortality and causes of death. Am J Cardiol 53: 9D–14D

    Google Scholar 

  17. Impact research group (1984) International mexiletine and placebo antiarrhythmic coronary trial I. Report on arrhythmia and other findings. J Am Coll Cardiol 4: 1148–1163

    Article  Google Scholar 

  18. Julian DG, Prescott PJ, Jackson FS, Szekely P (1982) Controlled trial of Sotalol for one year after myocardial infarction. Lancet 1: 1142–1147

    Article  PubMed  CAS  Google Scholar 

  19. Kennedy HL, Whitlock JA, Sprague BG, Kennedy LJ, Buckingham TA, Goldberg RJ (1985) Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. New Engl J Med 312: 193–197

    Article  PubMed  CAS  Google Scholar 

  20. Klein RC, Machell C (1989) Use of electrophysiologic testing in patients with nonsustained tachycardia: Prognostic and therapeutic implications. J Am Coll Cardiol 14: 155–161

    Google Scholar 

  21. Kosowsky BD, Taylor J, Lown B, Ritchie RF (1973) Longterm use of procainamide following acute myocardial infarction. Circulation 47: 1204–1210

    PubMed  CAS  Google Scholar 

  22. Kostis JB, Wilson AC, Sanders MR, Byington RP, BHAT-study group (1988) Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. Am J Cardiol 61: 975–978

    Article  Google Scholar 

  23. Kowey PR, Waxman HL, Greenspon A, Greenberg R, Poll D, Kutalek S, Gessman L, Muenz L, Philadelphia Arrhythmia group (1990) Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Am J Cardiol 65: 594–598

    Article  PubMed  CAS  Google Scholar 

  24. Lopressor intervention trial research group (1987) Multicenter study of metoprolol in survivors of acute myocardial infarction. Eur Heart J 8: 1056–1064

    Google Scholar 

  25. Miller JM, Kienzle MG, Harken AH, Josephson ME (1984) Morphologically distinct sustained ventricular tachycardias in coronary artery disease: Significance and surgical results. J Am Coll Cardiol 4: 1073–1079

    Article  PubMed  CAS  Google Scholar 

  26. Mitchell LB, Duff HJ, Manyari DE, Wyse DG (1987) A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia. New Engl J Med 317: 1681–1687

    Article  PubMed  CAS  Google Scholar 

  27. Multicenter international study (1977) Supplementary report. Reduction in mortality after myocardial infarction with long-term betaadrenoceptor blockade. Br Med J 2: 419–421

    Article  Google Scholar 

  28. Olsson G, Rehnquist N, Sjögren A, Erhardt L, Lundman TJ (1985) Long-term treatment with metoprolol after myocardial infarction: Effect of 3 year mortality and morbidity. J Am Coll Cardiol 5: 1428–1437

    Article  PubMed  CAS  Google Scholar 

  29. Peter T, Ross D, Duffield A, Luxton M, Harper, Hunt D, Sloman G (1978) Effect on survival after myocardial infarction of long-term treatment with phenytoin. Br Heart J 40: 1356–1360

    Article  PubMed  CAS  Google Scholar 

  30. Pryor DB, Bruce RA, Chaitman BR, Fisher L, Gajewski J, Hammermeister KE, Pauker SG, Stokes J (1989) Task force I: Determination of prognosis in patients with ischemia heart disease. J Am Coll Cardiol 14: 1016–1042

    Google Scholar 

  31. Ruberman W, Weinblatt E, Goldberg JD, Frank CW, Chaudary BC, Shapiro S (1981) Ventricular premature complexes and sudden death after myocardial infarction. Circulation 64: 297–305

    Article  PubMed  CAS  Google Scholar 

  32. Ryden L, Amman K, Conradson TB, Hofvendahl S, Mortensen O, Smedgard P (1980) Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction. Am Heart J 100: 1006–1012

    Article  PubMed  CAS  Google Scholar 

  33. Salathia KS, Barber JM, Mcilmoyle EL, Nicjolas J, Evans AE, Elwood JH, Cran G, Shanks RG, Mcboyle DM (1985) Very early intervention with metoprolol in suspected acute myocardial infarction. Eur Heart J 6: 190–198

    PubMed  CAS  Google Scholar 

  34. Schmidt G (1989) Antiarrhythmische Therapie: Kardiodepressive Nebenwirkungen. Schattauer, New York, S 97

    Google Scholar 

  35. Taylor SH, Silke B, Ebbutt A, Sutton GC, Prout BJ, Burley DM (1982) A long-term prevention study with oxprenolol in coronary heart disease. New Engl J Med 307: 1293–1301

    Article  PubMed  CAS  Google Scholar 

  36. Tchou PJ, Kadri P, Anderson J, Careres JA, Jazayeri M, Akhtar M (1988) Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med 109: 529–534

    PubMed  CAS  Google Scholar 

  37. The European Infarction study group (1984) European study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality. Eur Heart J 5: 189–202

    Google Scholar 

  38. The norwegian multicenter study group (1981) Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New Engl J Med 304: 801–807

    Article  Google Scholar 

  39. Van Durme JP, Hagemeijer F, Bogaert M, Glaser B, Hugenholtz PG (1977) Chronic antidysrhythmic treatment after myocardial infarction. Design of Ghent — Rotterdam aprindine study. In: Boissel JP, Klimt CR (eds) Multicenter controlled trials: principles and problems. Inserm, Paris, pp 43–48

    Google Scholar 

  40. Wilhemsson C, Verdin JA, Wilhemsson L, Tibblin G, Werko L (1974) Reduction of sudden death after myocardial infarction by treatment with alprenolol: Preliminary results. Lancet 92: 1157–1160

    Article  Google Scholar 

  41. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T (1989) Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 13: 1353–1361

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Herz- u. Kreislaufforschung, Wiltbergstraße 50, O-1115, Berlin-Buch, Germany

    Dr. sc. med. D. Pfeiffer (Oberarzt)

Authors
  1. Dr. sc. med. D. Pfeiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. I. Medizinische Klinik, Technischen Universität München Klinikum rechts der Isar, Ismaninger Straße 22, 8000, München 80, Germany

    Georg Schmidt

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Pfeiffer, D. (1991). Klasse-I-Antiarrhythmika: Wer soll behandelt werden?. In: Schmidt, G. (eds) Medikamentöse Behandlung des Postinfarktpatienten nach CAST. Steinkopff. https://doi.org/10.1007/978-3-642-85414-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85414-9_5

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85415-6

  • Online ISBN: 978-3-642-85414-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation